Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Ann Neurol. 2012 Aug;72(2):234–240. doi: 10.1002/ana.23591

Table 1.

Baseline characteristics of cohort subjects

Characteristic n=469
Age in years, mean (±SD) 42 ± 10
Disease duration in years, median (± interquartile range) 5 (0, 35)
Female sex, n (%) 330 (70)
Hispanic ethnicity, n (%) 24 (5)
HLA-DRB1 positive, n (%) 214 (46)
Smoker, n (%) 56 (12)
Body mass index in kg/m2, mean (±SD) 25 ± 5
Clinically isolated syndrome, n (%) 90 (19)
Any MS treatment within prior year, n (%) 298 (64)
Use of second-line therapy in past year, n (%) 17 (4)
Use of multivitamin, n (%) 224 (48)
Use of vitamin D supplements, n (%) 40 (9)

SD= standard deviation